NURS 6521 Advanced Pharmacology
Midterm Exam
300+ Practice Questions with Answers &
Detailed Rationales
Latest 2026/2027 Update | Walden
University
This comprehensive practice examination contains 300+ multiple-choice
questions aligned with the NURS 6521 Advanced Pharmacology curriculum
at Walden University. The questions cover all major content areas including
Pharmacokinetics & Pharmacodynamics, Antibiotic & Antimicrobial Agents,
Cardiovascular & Renal Pharmacology, CNS & Pain Management, Endocrine
& Reproductive Systems, Geriatric & Pediatric Pharmacology, and Adverse
Effects & Drug Interactions . Each question includes a detailed rationale
explaining the correct answer.
SECTION I: PHARMACOKINETICS &
PHARMACODYNAMICS (Questions 1-40)
,Q1. First-pass metabolism occurs primarily in
which organ?
A) Kidneys
B) Lungs
C) Liver
D) Intestines
Correct Answer: C
Rationale: First-pass metabolism occurs when a
drug is metabolized in the liver before reaching
systemic circulation, reducing its bioavailability.
Drugs administered orally pass through the
hepatic portal system and undergo metabolism
by hepatic enzymes, particularly the CYP450
system. This is why some drugs require higher
oral doses than intravenous doses to achieve
therapeutic effects. Kidneys are responsible for
drug excretion, lungs are involved in elimination
of volatile drugs but are not the primary site of
first-pass metabolism, and intestinal metabolism
occurs to a lesser extent .
,Q2. Bioavailability refers to:
A) The distribution of a drug to target tissues
B) The amount of active drug that reaches
systemic circulation
C) The rate at which a drug is metabolized
D) The time required for drug excretion
Correct Answer: B
Rationale: Bioavailability is the fraction of the
administered drug dose that reaches systemic
circulation in its unchanged, active form.
Intravenous administration has 100%
bioavailability because the drug bypasses
absorption barriers. Oral bioavailability is
affected by first-pass metabolism, drug solubility,
and formulation factors. Distribution describes
drug movement from blood to tissues,
metabolism describes drug biotransformation,
, and excretion describes drug elimination from
the body .
Q3. A drug's half-life determines:
A) Its potency at receptor sites
B) Its duration of action and dosing interval
C) The rate of drug absorption
D) The extent of protein binding
Correct Answer: B
Rationale: Half-life (t½) is the time required for
plasma concentration to decrease by 50%. It
determines dosing frequency and time to reach
steady state. Drugs with shorter half-lives require
more frequent dosing, while longer half-lives
allow once-daily or extended-interval dosing.
Potency is determined by receptor affinity,
absorption rate is determined by drug
formulation and route, and protein binding
Midterm Exam
300+ Practice Questions with Answers &
Detailed Rationales
Latest 2026/2027 Update | Walden
University
This comprehensive practice examination contains 300+ multiple-choice
questions aligned with the NURS 6521 Advanced Pharmacology curriculum
at Walden University. The questions cover all major content areas including
Pharmacokinetics & Pharmacodynamics, Antibiotic & Antimicrobial Agents,
Cardiovascular & Renal Pharmacology, CNS & Pain Management, Endocrine
& Reproductive Systems, Geriatric & Pediatric Pharmacology, and Adverse
Effects & Drug Interactions . Each question includes a detailed rationale
explaining the correct answer.
SECTION I: PHARMACOKINETICS &
PHARMACODYNAMICS (Questions 1-40)
,Q1. First-pass metabolism occurs primarily in
which organ?
A) Kidneys
B) Lungs
C) Liver
D) Intestines
Correct Answer: C
Rationale: First-pass metabolism occurs when a
drug is metabolized in the liver before reaching
systemic circulation, reducing its bioavailability.
Drugs administered orally pass through the
hepatic portal system and undergo metabolism
by hepatic enzymes, particularly the CYP450
system. This is why some drugs require higher
oral doses than intravenous doses to achieve
therapeutic effects. Kidneys are responsible for
drug excretion, lungs are involved in elimination
of volatile drugs but are not the primary site of
first-pass metabolism, and intestinal metabolism
occurs to a lesser extent .
,Q2. Bioavailability refers to:
A) The distribution of a drug to target tissues
B) The amount of active drug that reaches
systemic circulation
C) The rate at which a drug is metabolized
D) The time required for drug excretion
Correct Answer: B
Rationale: Bioavailability is the fraction of the
administered drug dose that reaches systemic
circulation in its unchanged, active form.
Intravenous administration has 100%
bioavailability because the drug bypasses
absorption barriers. Oral bioavailability is
affected by first-pass metabolism, drug solubility,
and formulation factors. Distribution describes
drug movement from blood to tissues,
metabolism describes drug biotransformation,
, and excretion describes drug elimination from
the body .
Q3. A drug's half-life determines:
A) Its potency at receptor sites
B) Its duration of action and dosing interval
C) The rate of drug absorption
D) The extent of protein binding
Correct Answer: B
Rationale: Half-life (t½) is the time required for
plasma concentration to decrease by 50%. It
determines dosing frequency and time to reach
steady state. Drugs with shorter half-lives require
more frequent dosing, while longer half-lives
allow once-daily or extended-interval dosing.
Potency is determined by receptor affinity,
absorption rate is determined by drug
formulation and route, and protein binding
